VTCN1 and breast carcinoma: We thus determined whether B7-H4 dysregulation may induce chemoresistance in breast cancer cells by evaluating the IC50 values for Doxorubicin [30], Oxaliplatin [31, 32], Fluorouracil [33] and Gefitinib [34], four commonly used chemotherapy in breast cancer patients.